EzriCare Artificial Tears Recall | Eye Drops Lawsuit

ezricare eye drops artificial tears product

The FDA recommended a recall of Global Pharma’s EzriCare Artificial Tears after bacterial contamination was linked to dozens of adverse health events, including hospitalizations, permanent vision loss, and at least one death.

If you or a loved one was injured as a result of using EzriCare eye drops, contact our dedicated legal team for a free case evaluation today.

About EzriCare Eye Drops

Ezricare Artificial Tears are over-the-counter products manufactured by Global Pharma Healthcare Private Limited and are intended to be sterile. They are used to relieve dry, itchy, and irritated eyes.

Ezricare Artificial Tears (Eye Drops) Recall

The U.S. Food and Drug Administration (FDA) announced a recommendation for an Artificial Tears recall on February 2, 2023, citing an increased risk of eye infections that could result in blindness or death. The recall impacts multiple versions of the lubricant eye drops sold in 15 ml bottles. The recall included the following products with the following UPC and NDC codes:

  • Ezricare (blue box): NDC 79503-0101-15 with UPC 3 79503 10115 7, and
  • Delsam Pharma (white box): NDC 72570-121-15 with UPC -72570-0121-15

The FDA instructed customers to stop using these products immediately and warned that at least 55 individuals had developed bacterial infections (Pseudomonas aeruginosa) after using eye drops between May 17, 2022 and January 19, 2023, with most reporting exposure to the Artificial Tears products.

Among the reported injuries, the FDA became aware of multiple individuals suffering permanent vision loss from eye infections, and at least one individual who died from a severe bloodstream infection.

The FDA reported that Global Pharma’s current good manufacturing practice (cGMP) violations, including lack of appropriate microbial testing, formulation issues, and lack of proper packaging controls contributed to the FDA’s recall recommendation.

Global Pharma Healthcare Private Limited has also been placed on import alert for providing an inadequate response to a records request and for lack of compliance with CGMP requirements.

Contact an Eye Drops Lawyer Today

Harding Mazzotti, LLP is accepting cases on behalf of those who used EzriCare Artificial Tears or Delsam Pharma Artificial tears and have experienced:

  • Eye Infection
  • Partial Blindness
  • Permanent Blindness
  • Bloodstream Infection
  • Carbapenem-Resistant Pseudomonas Aeruginosa (CRPA)

If you or a loved one have used EzriCare or Delsam Pharma eye drops products and have experienced one of the above ailments as a result, contact the trusted lawyers at Harding Mazzotti, LLP. Click, chat, or call 1(800) 529-1010 24/7 for a free case evaluation. Our experts can help you determine the best course of action to receive the compensation you deserve.

Don’t Wait Call Today!